Carbone, Carmine
 Distribuzione geografica
Continente #
NA - Nord America 1.908
EU - Europa 1.735
AS - Asia 1.217
SA - Sud America 165
AF - Africa 17
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.052
Nazione #
US - Stati Uniti d'America 1.884
CN - Cina 495
GB - Regno Unito 425
SG - Singapore 425
IT - Italia 307
DE - Germania 251
HK - Hong Kong 165
SE - Svezia 155
FI - Finlandia 151
BR - Brasile 147
IE - Irlanda 127
RU - Federazione Russa 110
FR - Francia 107
VN - Vietnam 48
NL - Olanda 26
KR - Corea 24
UA - Ucraina 22
BE - Belgio 14
CA - Canada 14
ID - Indonesia 12
JP - Giappone 12
AT - Austria 11
ES - Italia 8
MX - Messico 7
TR - Turchia 7
BD - Bangladesh 6
ZA - Sudafrica 6
AU - Australia 5
PL - Polonia 5
PY - Paraguay 5
TG - Togo 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
EU - Europa 3
IN - India 3
JO - Giordania 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
CL - Cile 2
CO - Colombia 2
EG - Egitto 2
HN - Honduras 2
IQ - Iraq 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MA - Marocco 2
PE - Perù 2
TW - Taiwan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
KE - Kenya 1
KH - Cambogia 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 5.052
Città #
Southend 389
Chandler 357
Dallas 211
Singapore 199
Ashburn 163
Hong Kong 157
Woodbridge 152
Dublin 127
Jacksonville 124
Munich 124
Verona 114
Beijing 91
Helsinki 89
Ann Arbor 75
Jinan 53
Wilmington 40
Lawrence 38
Princeton 38
Redmond 37
Nanjing 34
Houston 33
New York 33
Shenyang 33
The Dalles 32
Hebei 24
Tianjin 23
Turku 21
Dong Ket 20
Los Angeles 18
Haikou 15
São Paulo 15
Taiyuan 15
Brussels 14
Nanchang 14
Zhengzhou 14
Guangzhou 13
Sindelfingen 13
Columbus 12
Milan 12
Ningbo 11
Seattle 11
Tokyo 11
Changsha 10
Council Bluffs 10
Jakarta 10
Bologna 9
Chicago 9
Frankfurt am Main 9
Jiaxing 9
Redwood City 9
Boardman 8
Hangzhou 8
Kent 8
Rio de Janeiro 8
Santa Clara 8
Vienna 8
Buffalo 7
Hanoi 7
Norwalk 7
Nuremberg 7
San Francisco 7
Washington 7
Jyväskylä 6
Taizhou 6
Atlanta 5
Brasília 5
Brooklyn 5
Fairfield 5
Isola della Scala 5
Lappeenranta 5
Modena 5
Nürnberg 5
Seoul 5
Amsterdam 4
Belo Horizonte 4
Cagliari 4
Dearborn 4
Falls Church 4
Fuzhou 4
Ho Chi Minh City 4
Lancaster 4
Lanzhou 4
Lomé 4
London 4
Madrid 4
Montreal 4
Phoenix 4
Redondo Beach 4
Rome 4
Stockholm 4
Warsaw 4
Asunción 3
Boston 3
Charlotte 3
Clearwater 3
Elora 3
Johannesburg 3
Mexico City 3
Toronto 3
Almaty 2
Totale 3.339
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 249
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 216
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 208
Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment 188
Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype. 177
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 159
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 155
NF-κB as a target for pancreatic cancer therapy. 153
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 153
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 141
A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer 136
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis 132
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance 130
TGF-beta-activated Kinase 1 (TAK1) is a therapeutic target modulating pancreatic cancer chemoresistance 129
Modulation of pancreatic cancer chemoresistance by inhibition of TAK1. 128
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 128
Anti- VEGF treatment resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype 125
Current Strategies to Overcome Resistance to ALK-Inhibitor Agents 124
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 123
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 122
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 121
Pro-inflammatory factors secreted by pancreatic cancers with evasive resistance to anti-VEGF treatment contribute to malignant progression by inducing EMT 120
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 119
Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy 108
Molecular alterations in basal cell carcinoma subtypes 102
EMT and Treatment Resistance in Pancreatic Cancer 98
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 96
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia 94
Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validation 92
Toll-Like Receptor 9 Agonists for Cancer Therapy 90
PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around 89
MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity 88
Molecular analysis of a male breast cancer patient with prolonged stable disease under mTOR/PI3K inhibitors BEZ235/everolimus 87
TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy 86
Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversible by blood transfusion 80
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 76
Rationale and clinical use of multitargeting anticancer agents. 72
Local ablation disrupts immune evasion in pancreatic cancer 65
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC 59
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 58
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat 54
Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasis 52
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC 51
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer 43
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer 35
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story 27
Totale 5.138
Categoria #
all - tutte 19.282
article - articoli 17.634
book - libri 0
conference - conferenze 1.060
curatela - curatele 0
other - altro 588
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.564


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021311 0 0 20 53 42 39 7 8 10 55 34 43
2021/2022436 40 150 17 37 11 5 8 24 9 12 19 104
2022/2023820 70 104 75 149 52 200 4 46 96 7 11 6
2023/2024491 13 22 36 54 52 71 27 77 6 35 73 25
2024/20251.292 51 55 51 174 55 78 120 88 213 78 117 212
2025/2026584 212 161 211 0 0 0 0 0 0 0 0 0
Totale 5.138